Press Releases

PROVIDENCE, R.I., Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" in

FRANKFURT, Germany, Nov. 6, 2019 /PRNewswire/ -- (Booths #F62 & #F10 -Hall 11.1)  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in inno

BOULDER, Colo., Nov. 6, 2019 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2020 second quarter that ended September 30, 2019

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- IRLAB announced today that drug candidates IRL942 and IRL1009 have been granted composition of matter patents in the US and Europe from respective authorities. The preclinical drug candidates are currently undergoing preparatory steps to meet the regulatory requirements for obtaining permission t

HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation in the industry through its best-in-class CESS® nanonization

SAN FRANCISCO, Nov. 6, 2019 /PRNewswire/ -- Today, Cricket Health, a comprehensive kidney care provider, published a white paper, "Machine Learning for Chronic Kidney Disease Detection & Risk Stratification," announcing its proprietary machine learning model to identify patients at-risk for or living with chronic kidney disease (CKD). Designed by Cricket

LEEDS, England, Nov. 6, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a clinical-stage pharmaceutical company leading the development of Live Biotherapeutics, today announced preliminary safety and clinical observations from an ongoing Phase I/II clinical trial, in collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ

HONG KONG and SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Ping An Insurance (Group) of Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx: 2318; SSE: 601318) is proud to represent the financial technology sector as a partner of UNLEASH 2019, the global innovation lab for sustainable development, in

OSLO, Nov. 6, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces today that the primary endpoint of Overall Response Rate (ORR) has been met in Cohort A of its Phase II clinical trial (BGBC008) evaluating bemcentinib, its first in class sel

Medical business to drive future growth of Olympus Corporation as a global medtech leader A thorough transformation plan implemented to drive the change from within and ensure goals are achieved As a result >20% operating profit margin is targeted at the fiscal year March 2023 TOKYO, Nov. 6, 2019